Ernexa Therapeutics Inc. Preferred Stock, Liquidation Preference Per Share
Ernexa Therapeutics Inc. (ERNA) had Preferred Stock, Liquidation Preference Per Share of $156.00 per share as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Balance Sheet › Equity
us-gaap:PreferredStockLiquidationPreference · last filed 2017-11-08
- 2017-09-30: Preferred Stock, Liquidation Preference Per Share $156.00.
- 2017-06-30: Preferred Stock, Liquidation Preference Per Share $156.00.
- 2017-03-31: Preferred Stock, Liquidation Preference Per Share $156.00.
- 2016-12-31: Preferred Stock, Liquidation Preference Per Share $156.00.
| Period end | Preferred Stock, Liquidation Preference Per Share | Preferred Stock, Liquidation Preference Per Share as first filed |
|---|---|---|
| 2017-09-30 | $156.00 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $156.00 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $156.00 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $156.00 10-Q · filed 2017-11-08 | |
| 2016-09-30 | $156.00 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $156.00 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $156.00 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $156.00 10-K · filed 2017-03-09 | |
| 2015-09-30 | $156.00 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $156.00 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $156.00 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $156.00 10-K · filed 2016-03-15 | |
| 2014-09-30 | $156.00 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $156.00 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $156.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $156.00 10-Q · filed 2014-11-07 | |
| 2013-09-30 | $156.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $156.00 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $156.00 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $156.00 10-Q · filed 2013-11-14 | |
| 2012-09-30 | $156.00 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $156.00 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $161.00 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $156.00 10-K · filed 2013-03-29 | $161.00 10-K · filed 2012-03-30 |
| 2011-09-30 | $161.00 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $161.00 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $161.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |